Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer.
about
Recurrent hyperactive ESR1 fusion proteins in endocrine therapy resistant breast cancer.Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced cancers of the gastrointestinal tract or anus.High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy.
P2860
Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Hybrid capture-based genomic p ...... tive metastatic breast cancer.
@en
Hybrid capture-based genomic p ...... tive metastatic breast cancer.
@nl
type
label
Hybrid capture-based genomic p ...... tive metastatic breast cancer.
@en
Hybrid capture-based genomic p ...... tive metastatic breast cancer.
@nl
prefLabel
Hybrid capture-based genomic p ...... tive metastatic breast cancer.
@en
Hybrid capture-based genomic p ...... tive metastatic breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Hybrid capture-based genomic p ...... itive metastatic breast cancer
@en
P2093
A B Schrock
A D Hoffman
B Leyland-Jones
D M Lipson
D M Nguyen
G M Frampton
P2860
P304
P356
10.1093/ANNONC/MDX490
P577
2017-11-01T00:00:00Z